Hope and help for your gastroparesis patients
Gastroparesis can be a frustrating condition to treat. But with Enterra® Therapy, you can offer a minimally invasive, advanced treatment option in your patient’s journey to relief from nausea and vomiting.
Target your patients’ nausea and vomiting symptoms
Enterra Therapy is the first and only device designed to reduce the nausea and vomiting
secondary to gastroparesis through gastric electrical stimulation (GES).
It is CE Marked and supported by the National Institute for Health and Care Excellence (NICE) guidelines.
Long-term studies show significant improvement in nausea and vomiting symptoms
Reduction in
median weekly vomiting1,2
87%
among idiopathic patients
Idiopathic group:
N=18, P<0.001
12 month follow-up
68%
among diabetic patients
Diabetic group:
N=36, P<0.001
12 month follow-up
Recommending the right patients for Enterra® Therapy
Enterra Therapy may be appropriate for patients who meet the following criteria:
- have diffculty managing nausea and vomiting symptoms, despite having tried firstline therapies of diet modifications and medications
- are 18-70 of age
Find an implanter or GI specialist
If you have a patient who may be a candidate for receiving Enterra Therapy, use this tool to find a trained implanter or GI specialist in your area.
- McCallum RW, Sarosiek I, Parkman HP, Snape W, Brody F, Wo J, Nowak T. Gastric electrical stimulation with Enterra therapy improves symptoms of idiopathic gastroparesis. Neurogastroenterol Motil. 2013 Oct;25(10):815-e636.
- McCallum RW, Snape W, Brody F, Wo J, Parkman HP, Nowak T. Gastric electrical stimulation with Enterra therapy improves symptoms from diabetic gastroparesis in a prospective study. Clin Gastroenterol Hepatol. 2010;8(11):947-e116. doi:10.1016/j.cgh.2010.05.020.
IMPORTANT SAFETY INFORMATION
The Enterra Therapy System for gastric electrical stimulation (GES) is indicated for the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis.